发明授权
US08980920B2 Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C
有权
三个连接的芳基部分的抗病毒化合物来治疗诸如丙型肝炎的疾病
- 专利标题： Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C
- 专利标题（中）： 三个连接的芳基部分的抗病毒化合物来治疗诸如丙型肝炎的疾病
-
申请号： US13375094申请日： 2010-05-28
-
公开(公告)号： US08980920B2公开(公告)日： 2015-03-17
- 发明人: Qingbei Zeng , Kevin X. Chen , Anilkumar Gopinadhan Nair , Stuart B. Rosenblum , Joseph A. Kozlowski , F. George Njoroge
- 申请人： Qingbei Zeng , Kevin X. Chen , Anilkumar Gopinadhan Nair , Stuart B. Rosenblum , Joseph A. Kozlowski , F. George Njoroge
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 代理商 Jeffrey P. Bergman; Laura M. Ginkel
- 国际申请： PCT/US2010/036523 WO 20100528
- 国际公布： WO2010/138791 WO 20101202
- 主分类号： A61K31/41
- IPC分类号： A61K31/41 ; A61K31/4192 ; A61K31/4439 ; A61K31/423 ; A61K31/5377 ; A61K31/496 ; A61K31/427 ; A61K31/422 ; A61K31/4196 ; C07D213/60 ; C07D233/64 ; C07D235/04 ; C07D239/28 ; C07D241/14 ; C07D403/14
摘要：
The present invention relates to novel Linked Tricyclic Aryl Compounds, compositions comprising at least one Linked Tricyclic Compound, and methods of using Linked Tricyclic Aryl Compounds for treating or preventing HCV infection in a patient. in one aspect, the present invention provides Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein: Non-limiting examples of the Compounds of Formula (II) include compound 56.
公开/授权文献
信息查询
